Trademark: 97094701
Word
CERNOVEEN
Status
Pending
Status Code
733
Status Date
Friday, February 16, 2024
Serial Number
97094701
Mark Type
4000
Filing Date
Wednesday, October 27, 2021
Published for Opposition
Tuesday, February 15, 2022

Trademark Owner History
Azurity Pharmaceuticals, Inc. - Owner At Publication

Classifications
5 pharmaceutical preparations for use in the treatment of seizures, bipolar disorders, depression and neurofibromatosis; pharmaceutical preparations for the prevention and treatment of central nervous system disorders, neurological diseases and disorders, neurodegenerative disorders, and depression

Trademark Events
Feb 17, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 16, 2024
Sou Extension 4 Granted
Feb 16, 2024
Sou Extension 4 Filed
Feb 16, 2024
Sou Teas Extension Received
Aug 25, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 23, 2023
Sou Extension 3 Granted
Aug 23, 2023
Sou Extension 3 Filed
Aug 23, 2023
Sou Teas Extension Received
Mar 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2023
Sou Extension 2 Granted
Mar 15, 2023
Sou Extension 2 Filed
Mar 15, 2023
Sou Teas Extension Received
Aug 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 25, 2022
Sou Extension 1 Granted
Aug 25, 2022
Sou Extension 1 Filed
Aug 25, 2022
Sou Teas Extension Received
Apr 12, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 15, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 15, 2022
Published For Opposition
Jan 26, 2022
Notification Of Notice Of Publication E-Mailed
Jan 10, 2022
Approved For Pub - Principal Register
Jan 7, 2022
Assigned To Examiner
Nov 9, 2021
New Application Office Supplied Data Entered

Trademark Alertz updated from USPTO on 2030-01-24